The Amyloidosis Channel is supported with funding from Prothena (Silver).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
VJVirtual | Early vs. deferred transplantation in AL amyloidosis
Surbhi Sidana, MD, Mayo Clinic, Stanford, CA, compares early versus deferred stem-cell transplantation for amyloid light-chain (AL) amyloidosis patients, as evaluated in a retrospective study comparing overall survival between patients who proceed directly to autologous stem cell transplant after stem cell collection and those who defer. This interview was recorded via an online conference call with the Video Journal of Hematological Oncology (VJHemOnc).
